Stephen P. Fortmann, MD

Senior Investigator
Assistant Program Director
Steve Fortmann

Dr. Stephen Fortmann is an internist and epidemiologist who conducts research on heart disease prevention. He has conducted both population- and individual-level studies of cardiovascular risk factors and disease rates, smoking cessation, health education through the mass media, and exercise and diet change. He is also an expert on the clinical management of lipid disorders.

Since coming to the Center for Health Research in 2010, Dr. Fortmann has focused on community-based research. He is a co-investigator on a study of diabetes incidence, treatment, and complications in South Asians, Chinese, and other Asian ethnic subgroups in California and a study of diabetes disparities in Asian and Pacific Islander populations in Hawaii. He is a co-investigator on the Community Health Applied Research Network Data Coordinating Center (CHARN), the data hub for a network of federally qualified health centers and their university partners established to facilitate research among underserved populations. He is also a co-investigator on a study examining whether the Oregon Medicaid “lottery” differentially affected established community health center patients, and how insurance coverage is associated with receipt of preventive services among these patients.

He serves as principal investigator of the scientific coordinating center for the federal Centers for Education and Research on Therapeutics (CERTs) program, funded by the Agency for Healthcare Research and Quality (AHRQ). The CERTs program draws together six research centers across the U.S. that conduct research on therapeutics.

Dr. Fortmann has extensive experience leading interdisciplinary research, beginning with his work on the Stanford Five-City Project, a community cardiovascular disease prevention study funded by the National Heart, Lung, and Blood Institute. He also helped to initiate the World Health Organization’s MONICA Project, an international study of trends in heart disease rates. Most of his past work has been funded by the National Institutes of Health and the California Tobacco-Related Disease Research Program.

Dr. Fortmann has more than 30 years of experience directing community and clinical trials, and he has published more than 160 peer-reviewed journal articles.

Dr. Fortmann came to CHR from Stanford University Medical School, where he was a faculty member and director of the Stanford Prevention Research Center and the Stanford Preventive Cardiology Clinic. He is now the C. F. Rehnborg Professor in Disease Prevention (Emeritus) at Stanford. In 2005, he was elected to the Institute of Medicine of the National Academies of Science. Dr. Fortmann received his MD from the University of California, San Francisco, and postdoctoral training in cardiovascular disease prevention at Stanford University.


Back to Investigators »

Recent Publications

Pearson TA, Palaniappan LP, Artinian NT, Carnethon MR, Criqui MH, Daniels SR, Fonarow GC, Fortmann SP, Franklin BA, Galloway JM, Goff DC, Heath GW, Frank ATH, Kris-Etherton PM, Labarthe DR, Murabito JM, Sacco RL, Sasson C, Turner MB. American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 Update: A Scientific Statement for Public Health Practitioners, Healthcare Providers, and Health Policy Makers. Circulation 2013; 127(16): 1730-53. [Epub 2013 Mar 21; doi: 10.1161/CIR.0b013e31828f8a94] [PMID 23519758; PMC 35863531].   PubMed abstract
Smith DH, Johnson ES, Boudreau DM, Cassidy-Bushrow AE, Fortmann SP, Greenlee RT, Gurwitz JH, Magid DJ, McNeal CJ, Reynolds K, Steinhubl SR, Thorp M, Tom JO, Vupputuri S1, VanWormer JJ, Weinstein J, Yang X, Go AS, Sidney S. Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort Study. Am J Med. 2015 Jul 11. [Epub ahead of print]   PubMed abstract
Solbert LI, Bailey S, Kurtz SE, McBurnie MA, Priest E, Masica A, Puro JE, Williams R, Fortmann S, Williams A, Hazlehurst BL. Assessing trends in tobacco cessation in diverse patient populations.Nicotine Tob Res. 2015 Apr 28. [Epub 2015 Apr 28]   PubMed abstract
Stevens VJ, Solberg LI, Bailey S, Kurtz SE, McBurnie MA, Priest EL, Puro JE, Williams R, Fortmann SP, Hazlehurst BL. Assessing trends in tobacco cessation in diverse patient populations. Nicotine Tob Res 2015 Apr 28. [Epub 2015 Apr 28]  
Fortmann SP, Whitlock EP, Burda BU. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer. Ann Intern Med. 2014 May 6;160(9):656.   
Frank ATH, Zhao B, Jose PO, Azar KMJ, Fortmann SP, Palaniappan LP. Racial/Ethnic differences in dyslipidemia patterns. Circulation. 2014 Feb 4;129(5):570-9. [Epub 2013 Nov 5] PMC Journal – In Process   PubMed abstract
Gold R, Bailey SR, O’Malley JP, Hoopes MJ, Cowburn S, Marino M, Heintzman J, Nelson C, Fortmann SP, DeVoe JE. Estimating demand for care after a Medicaid expansion: Lessons from Oregon. J Ambul Care Manage. 2014 Apr 1. [Epub 2014 Apr 1]   PubMed abstract
Nichols GA, Rosales AG, Perrin NA, Fortmann SP. The association between different A1C-based measures of glycemia and risk of cardiovascular disease hospitalization. Diabetes Care 2014 Jan;37(1):167-72. [Epub 2013 Aug 29] PMCID: PMC3867992 [Available on 2015/1/1]   Full text
Bhalla V, Zhao B, Azar KMJ, Choi S, Wong E, Fortmann SP, Palaiappan LP. Racial/ethnic differences in the prevalence of proteinuric and non-proteinuric diabetic kidney disease. Diabetes Care 2013 May;36(5):1215-21. [Epub 2012 Dec 13] PMC3631839   Full text
Dauphineé AL, Doxey JR, Schleicher NC, Fortmann SP, Henriksen L. Racial differences in cigarette brand recognition and impact on youth smoking. BMC Public Health 2013 Feb 25; 13(1):170. PMC3586353   Full text

More Publications »
Kaiser Permanente